<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Hum Mol Genet</journal-id>
<journal-id journal-id-type="iso-abbrev">Hum. Mol. Genet</journal-id>
<journal-id journal-id-type="publisher-id">hmg</journal-id>
<journal-id journal-id-type="hwp">hmg</journal-id>
<journal-title-group>
<journal-title>Human Molecular Genetics</journal-title>
</journal-title-group>
<issn pub-type="ppub">0964-6906</issn>
<issn pub-type="epub">1460-2083</issn>
<publisher>
<publisher-name>Oxford University Press</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">27412009</article-id>
<article-id pub-id-type="pmc">6283265</article-id>
<article-id pub-id-type="doi">10.1093/hmg/ddw191</article-id>
<article-id pub-id-type="publisher-id">ddw191</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Invited Reviews</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Pathogenetics of the RASopathies</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Tidyman</surname>
<given-names>William E.</given-names>
</name>
<xref ref-type="aff" rid="ddw191-aff1">1</xref>
<xref ref-type="aff" rid="ddw191-aff3">3</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Rauen</surname>
<given-names>Katherine A.</given-names>
</name>
<xref ref-type="aff" rid="ddw191-aff2">2</xref>
<xref ref-type="aff" rid="ddw191-aff3">3</xref>
<xref ref-type="corresp" rid="ddw191-cor1">*</xref>
<!--<email>rauen@ucdavis.edu</email>-->
</contrib>
</contrib-group>
<aff id="ddw191-aff1">
<label><sup>1</sup></label>Division of Behavioral and Developmental Pediatrics, Department of Pediatrics</aff>
<aff id="ddw191-aff2">
<label><sup>2</sup></label>Department of Pediatrics, Division of Genomic Medicine, University of California Davis, Sacramento, CA, USA</aff>
<aff id="ddw191-aff3">
<label><sup>3</sup></label>UC Davis MIND Institute, Sacramento, CA 95817, USA</aff>
<author-notes>
<corresp id="ddw191-cor1">*To whom correspondence should be addressed at: UC Davis MIND Institute, 2825 50th Street, Room 2284, Sacramento, CA 95817, USA. Tel: 916 7030204; Fax: 916 7030243; Email: <email>rauen@ucdavis.edu</email></corresp>
</author-notes>
<pub-date pub-type="ppub">
<day>01</day>
<month>10</month>
<year>2016</year>
</pub-date>
<pub-date iso-8601-date="2016-07-12" pub-type="epub">
<day>12</day>
<month>7</month>
<year>2016</year>
</pub-date>
<volume>25</volume>
<issue>R2</issue>
<fpage>R123</fpage>
<lpage>R132</lpage>
<history>
<date date-type="received">
<day>06</day>
<month>6</month>
<year>2016</year>
</date>
<date date-type="rev-recd">
<day>6</day>
<month>6</month>
<year>2016</year>
</date>
<date date-type="accepted">
<day>15</day>
<month>6</month>
<year>2016</year>
</date>
</history>
<permissions>
<copyright-statement>Â© The Author 2016. Published by Oxford University Press. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com</copyright-statement>
<copyright-year>2016</copyright-year>
</permissions>
<abstract>
<title>Abstract</title>
<p>The RASopathies are defined as a group of medical genetics syndromes that are caused by germ-line mutations in genes that encode components or regulators of the Ras/mitogen-activated protein kinase (MAPK) pathway. Taken together, the RASopathies represent one of the most prevalent groups of malformation syndromes affecting greater than 1 in 1,000 individuals. The Ras/MAPK pathway has been well studied in the context of cancer as it plays essential roles in growth, differentiation, cell cycle, senescence and apoptosis, all of which are also critical to normal development. The consequence of germ-line dysregulation leads to phenotypic alterations of development. RASopathies can be caused by several pathogenetic mechanisms that ultimately impact or alter the normal function and regulation of the MAPK pathway. These pathogenetic mechanisms can include functional alteration of GTPases, Ras GTPase-activating proteins, Ras guanine exchange factors, kinases, scaffolding or adaptor proteins, ubiquitin ligases, phosphatases and pathway inhibitors. Although these mechanisms are diverse, the common underlying biochemical phenotype shared by all the RASopathies is Ras/MAPK pathway activation. This results in the overlapping phenotypic features among these syndromes.</p>
</abstract>
<counts>
<page-count count="10"></page-count>
</counts>
</article-meta>
</front>
</article>
</pmc-articleset>